Glucagon-like peptide 1 (GLP-1) is the most successful therapy after insulin for treating diabetes and many GLP-1 receptor agonists (GLP-1RAs) have been approved in recent years (Drucker, 2018). The gene discussed is GCG; the disease is diabetes mellitus.